KKPCF
Price:
$26
Market Cap:
$145.60B
Kaken Pharmaceutical Co., Ltd., a Tokyo-based company established in 1917, operates globally, specializing in the development, manufacture, and commercialization of a diverse array of medical products, medical devices, and agrochemicals. Its comprehensive portfolio spans various therapeutic areas. Key pharmaceutical offerings include Clenafin, a topical solution for onychomycosis; Artz, an anti-osteoarthritis medication; Seprafilm, an absorbable adhesion barrier used on damaged tissue; Fiblast, a spray designed for treating pressure and other skin ulcers; Regroth, a product aiding periodontal regeneration; and Hernicore, used for lumbar disc herniation. Other notable pharmaceutical products ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-12-09
Stock Exchange
OTC
Ticker
KKPCF
According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 288.89. This represents a change of 252.08% compared to the average of 82.05 of the last 4 quarters.
The mean historical PE Ratio of Kaken Pharmaceutical Co., Ltd. over the last ten years is 20.20. The current 288.89 PE Ratio has changed 142.93% with respect to the historical average. Over the past ten years (40 quarters), KKPCF's PE Ratio was at its highest in in the June 2025 quarter at 134.06. The PE Ratio was at its lowest in in the March 2022 quarter at -52.77.
Average
20.20
Median
12.91
Minimum
10.16
Maximum
73.21
Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 496.98%
Maximum Annual PE Ratio = 73.21
Minimum Annual Increase = -36.11%
Minimum Annual PE Ratio = 10.16
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | 73.21 | 496.98% |
| 2025 | 12.26 | -24.78% |
| 2024 | 16.30 | -36.11% |
| 2023 | 25.52 | 64.95% |
| 2022 | 15.47 | 23.97% |
| 2021 | 12.48 | 22.78% |
| 2020 | 10.16 | -11.68% |
| 2019 | 11.51 | -13.77% |
| 2018 | 13.35 | 13.88% |
| 2017 | 11.72 | -12.14% |
The current PE Ratio of Kaken Pharmaceutical Co., Ltd. (KKPCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
33.92
5-year avg
28.55
10-year avg
20.20
Kaken Pharmaceutical Co., Ltd.’s PE Ratio is greater than Luye Pharma Group Ltd. (10.68), greater than China Shineway Pharmaceutical Group Limited (5.60), greater than Adcock Ingram Holdings Limited (12.79), greater than Drägerwerk AG & Co. KGaA (10.75), greater than TerrAscend Corp. (-2.57), greater than PT Tempo Scan Pacific Tbk (8.29), greater than Biotest AG (-50.32), greater than Kossan Rubber Industries Bhd (18.90), greater than Columbia Care Inc. (-1.16), greater than Biotage AB (publ) (70.33),
| Company | PE Ratio | Market cap |
|---|---|---|
| 10.68 | $815.28M | |
| 5.60 | $758.42M | |
| 12.79 | $624.32M | |
| 10.75 | $1.56B | |
| -2.57 | $601.91M | |
| 8.29 | $463.12M | |
| -50.32 | $943.03M | |
| 18.90 | $839.59M | |
| -1.16 | $521.35M | |
| 70.33 | $1.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Kaken Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
What is the highest PE Ratio for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
What is the 3-year average PE Ratio for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
What is the 5-year average PE Ratio for Kaken Pharmaceutical Co., Ltd. (KKPCF)?
How does the current PE Ratio for Kaken Pharmaceutical Co., Ltd. (KKPCF) compare to its historical average?